On Tuesday, WoLF joined over fifty clinicians and researchers in ten different countries and multiple organizations in demanding that the Food and Drug Administration (FDA) take action against the off-label use of puberty blockers in children.

WoLF is disappointed to learn that the U.S. Supreme Court has declined to hear the case of Tingley v. Ferguson. The case centered around Washington state's SB 5722, a law that infringes on the rights of therapists and patients by mandating 'affirmation-only' therapy for minors with gender dysphoria.

The decision finally acknowledged what feminists have been saying for years: “Transgender” identification is neither an immutable status nor an oppressed class

Dangerous puberty blockers like Lupron are being prescribed to minors without FDA oversight - Act now to protect more children from harm!

WoLF Executive Director Sharon Byrne shares a letter following her first week on the frontlines of feminism. Join Sharon and the WoLF community to restore, protect, and advance the rights of women and girls!

AMC Theaters announced last week that it would be pulling screenings of, "No Way Back: The Reality of Gender-Affirming Care,” a 90-minute documentary examining the experiences of five detransitioners.

Washington State’s SB 5722 would require licensed therapists to use “affirmation-only” therapy and effectively ban mental health care for detransitioners

On January 26, 2023, WoLF submitted written testimony in support of Montana Senate Bill 99, the Youth Health Protection Act.

Despite its stated dedication to “the health of all children,” the AAP is leading the sterilization of a generation.

On January 24, WoLF submitted written testimony in support of three bills in Missouri to protect children from life-altering medical interventions.

Given the way some trans-identified people discuss hormones and surgeries as a ticket to their idealized lives in ways that extend beyond the direct cosmetic changes, it seems likely that displaced meaning is motivating some people to “transition.”

WoLF educated the NIH about research opportunities and needs related to “gender-affirming care,” including the physical and psychological impacts on female patients. 

The proposed HHS regulations will redefine discrimination on the basis of sex, expanding it so that “gender identity” will be considered a form of sex-based discrimination. If HHS is allowed to include “gender identity” as a form of sex-based discrimination, healthcare providers in a wide variety of government programs will be forced to provide “gender affirming” medical interventions to patients.

HHS has released proposed rulemaking titled Nondiscrimination in Health Programs and Activities. These proposed regulations threaten women’s sex-based rights and they threaten healthcare providers who do not want to provide harmful, unnecessary cosmetic medical interventions under the guise of “gender-affirming care.”

Last week, the 8th US Circuit Court of Appeals ruled against WoLF’s position in the Arkansas SAFE Act case, Brandt v. Rutledge.

Dr. Mahri Irvine, WoLF’s Executive Director, submitted written testimony in support of TN HB 2835 and SB 2696, two bills that would enact the “Youth Health Protection Act.” These bills provide a mechanism to protect children from unnecessary, life-altering, and permanent medical interventions that are frequently promoted by gender ideology activists.

In collaboration with Family Policy Alliance, the Women’s Liberation Front submitted written testimony on Thursday in support of Ohio House Bill 454. This bill, entitled the Save Adolescents from Experimentation (SAFE) Act, would prohibit hormonal and surgical procedures from being performed on minors for the purpose of “gender transition.”

WPATH, or the World Professional Association for Transgender Health, has recently updated its new standards of care.

WoLF submits Amicus Brief to oppose child “gender transition.”

The 8th Circuit brief was filed in support of the Arkansas SAFE Act which prohibits gender surgeries and drugs for children.